Healio_OSN Profile Banner
Ocular Surgery News Profile
Ocular Surgery News

@Healio_OSN

Followers
17K
Following
1K
Media
4K
Statuses
27K

The content you need, when you need it.

Thorofare
Joined March 2009
Don't wanna be here? Send us removal request.
@Healio_OSN
Ocular Surgery News
7 hours
🤰Indigenous women face stark differences in maternal outcomes compared with women of other races. 🪶In honor of #IndigenousPeoplesDay, we spoke with @DrRachelMBond and other experts about strategies to address health disparities among Indigenous women. https://t.co/S5kXjw1Flm
0
0
0
@Healio_OSN
Ocular Surgery News
12 hours
Teamwork between referrers and specialists = better patient outcomes. Tap in to learn more! 🔗 https://t.co/VU3cjTiFPK
0
0
0
@Healio_OSN
Ocular Surgery News
2 days
Virtual IOL implantation may eventually aid “in our quest to ‘trial’ different IOL types before surgical implantation.” George O. Waring IV, MD, FACS, shares his thoughts on a novel device.👇 https://t.co/G2fDO88UHz #Vision @georgewaring @GoHealio
0
1
1
@Healio_OSN
Ocular Surgery News
3 days
Patients experienced an improvement in uncorrected distance visual acuity and corrected distance visual acuity after adjustment of corneal allogeneic intrastromal ring segment procedures. Read more from @JRSJournal.👇 https://t.co/of7om9OK0U #Vision #Ophthalmology
Tweet card summary image
healio.com
Adjustment procedures can help improve suboptimal results after implantation of corneal allogeneic intrastromal ring segments, according to a study in Journal of Refractive Surgery. Soosan Jacob, MS,...
0
0
0
@Healio_OSN
Ocular Surgery News
4 days
❗ICYMI❗ Harrow entered into an agreement to acquire Melt Pharmaceuticals.   Harrow plans to submit a new drug application for MELT-300, a sublingually delivered formulation of midazolam and ketamine, in 2027. https://t.co/WNEZHFdIA6 #Vision
Tweet card summary image
healio.com
Harrow entered into an agreement to acquire Melt Pharmaceuticals and plans to submit a new drug application for MELT-300, Melt’s lead candidate, to the FDA in 2027. “MELT-300 integrates seamlessly...
1
0
1
@Healio_OSN
Ocular Surgery News
4 days
Educating patients improves adherence. Learn practical approaches in this CME ✅ https://t.co/o6FOBbkfIH
0
0
0
@Healio_OSN
Ocular Surgery News
4 days
❗New Exclusive❗ Research for oculomics, the study of the #eye as a window to systemic health, has expanded in recent years. What's driving this expansion? #AI. How can this lead to more equitable access to care? https://t.co/6BDbjRHibm @AndrewGoLeeMD
Tweet card summary image
healio.com
With AI moving at a fast pace, oculomics — the study of the eye as a window to systemic health — is expanding its potential and gaining increasing attention. The past few years have seen an abundance...
0
1
1
@Healio_OSN
Ocular Surgery News
5 days
👁️ Early planning, clear priorities and contract negotiation are essential for the #ophthalmology job hunt, Imane Tarib, MD, said at @RealWorldOphth’s #RWOFallMeeting. Learn more about the early-career job search here on @GoHealio. 👇 https://t.co/Prt9ptyEQH @DrEyeTarib
0
1
4
@Healio_OSN
Ocular Surgery News
5 days
#Eye on Efficiency returns❗ In the third episode, Cynthia Matossian, MD, FACS, talks with two experts about how technology can make scheduling and check-in easier for patients. Read, watch or listen.👇 https://t.co/zKuMX2C9pc #PracticeManagement #Vision @GoHealio
1
0
2
@Healio_OSN
Ocular Surgery News
5 days
🩺👁️ T2D + NPDR + center-involving DME—learn to tailor treatment for better outcomes! Start Now: https://t.co/W4HXewcwYT
0
0
2
@Healio_OSN
Ocular Surgery News
6 days
A 74-year-old patient was referred to a clinic for evaluation of a blind, painful right #eye and consideration of enucleation. Can you crack the case?🤔⬇️ https://t.co/5c3rjxtl0R #Vision #Ophthalmology
Tweet card summary image
healio.com
A 74-year-old man was referred to the oculoplastic service at Tufts Medical Center/New England Eye Center for evaluation of a blind, painful right eye and consideration of enucleation.The patient had...
0
0
0
@Healio_OSN
Ocular Surgery News
6 days
Recently, DefEYE, formerly a subsidiary of Verséa Health, launched as an independent company. DefEYE has a portfolio of decellularized biologics for ocular surgery and ocular surface management. Read more: https://t.co/mBdD1VrAl9 #Vision #Ophthalmology
Tweet card summary image
healio.com
DefEYE Inc., previously a subsidiary of Verséa Health operating as Verséa Ophthalmics, announced its launch as an independent company, according to a press release. DefEYE launched with a portfolio...
0
0
1
@RetinaWCongress
Retina World Congress
1 month
Retina World Congress brings together the full spectrum of the retina community. Whether you’re advancing clinical practice, pioneering research or exploring new technology, there’s a place for you to learn, connect and make an impact. #RetinaWorldCongress #Retina #Ophthalmology
0
1
0
@Healio_OSN
Ocular Surgery News
6 days
Elevate your expertise in DME care—complete this interactive CaseCare360 now! Get Started: https://t.co/YngCEjMw7M #HealioCME #FreeCME #MedicalEducation
0
0
0
@Healio_OSN
Ocular Surgery News
7 days
📰 Did you miss out on #RWO 2025? No worries, we’ve got you covered. Catch the highlights here: https://t.co/279uTswrRr Healio is proud to be an official RWO Media Partner.
0
0
2